Assessment of DNA/RNA Defend Pro: An Inactivating Sample Collection Buffer for Enhanced Stability, Extraction-Free PCR, and Rapid Antigen Testing of Nasopharyngeal Swab Samples
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25169097 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Mikhail Claeys und 4 weiteren Autor:innen. Beteiligte Einrichtung: InActiv Blue, Industriepark Oost 2A, 8730 Beernem, Belgium. Hauptthemen laut MEDLINE: Nasopharynx, Specimen Handling, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study comprehensively evaluated the DNA/RNA Defend Pro (DRDP) sample collection buffer, designed to inactivate and stabilize patient samples. The primary objectives were to assess DRDP’s efficacy in ensuring sample stability, facilitating extraction-free polymerase chain reaction (PCR), and ensuring compatibility with rapid antigen testing (RAT). Ninety-five diagnostic nasopharyngeal swab samples tested for influenza virus (influenza A), respiratory syncytial virus (RSV A), and/or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were 10-fold diluted with DRDP and anonymized. Initial characterization and retesting of these samples using cobas Liat confirmed 88 samples as positive, validating the presence of viral targets. Results from rapid antigen testing showed lower sensitivity compared to nucleic acid amplification testing (NAAT) but maintained perfect specificity, with 40 out of 88 positive samples by cobas Liat also testing positive for RAT. Direct RT-qPCR of DRDP-diluted samples demonstrated robust compatibility, with 72 out of 88 samples positive for cobas Liat also testing positive by direct RT-qPCR. Non-concordant results could be explained by the 200-fold lower input of extraction-free NAAT. Stability testing involved incubating 31 positive samples at 4 °C, 20 °C, and 37 °C for 7 days, with extraction-free NAAT. DRDP guaranteed viral RNA stability at all temperatures for influenza A, SARS-CoV-2, and RSV A, showing stability up to 7 days at 4 °C. In conclusion, DRDP is an effective stabilizing medium compatible with direct RT-qPCR and rapid antigen testing and shows great potential for optimizing diagnostic processes, particularly in resource-limited or time-sensitive scenarios.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- InActiv Blue, Industriepark Oost 2A, 8730 Beernem, Belgium.
- Campus Brugge Station, Howest University of Applied Sciences, Rijselstraat 5, 8200 Brugge, Belgium.
- Medisch Labo Bruyland, Beneluxpark 2, 8500 Kortrijk, Belgium.
- Department of Biomolecular Medicine, Ghent University, Corneel Heymanslaan 10, 9000 Gent, Belgium.
ORCID-Profile: Jo Vandesompele
Zitieren
APA
Claeys, M., Al Obaidi, S., Bruyland, K., Vandecandelaere, I., & Vandesompele, J. (2024). Assessment of DNA/RNA Defend Pro: An Inactivating Sample Collection Buffer for Enhanced Stability, Extraction-Free PCR, and Rapid Antigen Testing of Nasopharyngeal Swab Samples. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25169097
Vancouver
Claeys M, Al Obaidi S, Bruyland K, Vandecandelaere I, Vandesompele J. Assessment of DNA/RNA Defend Pro: An Inactivating Sample Collection Buffer for Enhanced Stability, Extraction-Free PCR, and Rapid Antigen Testing of Nasopharyngeal Swab Samples. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25169097
BibTeX
@article{Claeys2024,
author = {Claeys, Mikhail and Al Obaidi, Saif and Bruyland, Karen and Vandecandelaere, Ilse and Vandesompele, Jo},
title = {Assessment of DNA/RNA Defend Pro: An Inactivating Sample Collection Buffer for Enhanced Stability, Extraction-Free PCR, and Rapid Antigen Testing of Nasopharyngeal Swab Samples},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25169097}
}
EUVIMED